Company profile
FRESENIUS MEDICAL CARE AG
NYSE:FMSMisc Health and Biotechnology Services
Drug pipeline (24)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| CALCITRIOL | approved | — | 0 | — |
| DELFLEX W/ DEXTROSE 1.5% IN PLASTIC CONTAINER | approved | — | 5 | approved |
| DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM IN PLASTIC CONTAINER | approved | — | 5 | approved |
| DELFLEX W/ DEXTROSE 1.5% LOW MAGNESIUM LOW CALCIUM IN PLASTIC CONTAINER | approved | — | 5 | approved |
| DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER | approved | — | 5 | approved |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (41)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00915369 | phase1 | unknown | 2009-03-01 | 2010-04-01 | Fresenius Kabi Oncology Ltd. | A Clinical Trial to Study the Effects of Nanoparticle Based Paclitaxel Drug, Which Does Not Contain the Solvent Cremophor, in Advanced Breast Cancer |
| NCT04934072 | phase3 | completed | 2021-06-16 | 2023-08-07 | Fresenius Kabi SwissBioSim GmbH | A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis |
| NCT02795039 | phase1 | completed | 2016-06-01 | 2017-03-03 | Fresenius Kabi | Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects |
| NCT02086227 | phase1 | completed | 2013-05-01 | 2013-06-01 | Fresenius Kabi USA, LLC | Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories) |
| NCT03666546 | phase4 | completed | 2018-11-26 | 2019-03-05 | Fresenius Kabi | Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2 |
FDA applications (10)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| NDA 205109 | 2013-11-27 | NDA | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE | |||||
Loading… | ||||||||
| NDA 022581 | 2011-04-18 | NDA | FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP LLC | |||||
Loading… | ||||||||
| ANDA 078177 | 2007-04-12 | ANDA | FRESENIUS MEDICAL CARE NORTH AMERICA | |||||
Loading… | ||||||||
| ANDA 075766 | 2003-02-20 | ANDA | FRESENIUS MEDICAL CARE NORTH AMERICA | |||||
Loading… | ||||||||
| NDA 021160 | 2001-04-02 | NDA | FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP LLC | |||||
Loading… | ||||||||